{
     "PMID": "15850776",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20050721",
     "LR": "20131121",
     "IS": "0006-291X (Print) 0006-291X (Linking)",
     "VI": "331",
     "IP": "2",
     "DP": "2005 Jun 3",
     "TI": "Membrane cholesterol oxidation inhibits ligand binding function of hippocampal serotonin(1A) receptors.",
     "PG": "422-7",
     "AB": "We have monitored the ligand binding function of the bovine hippocampal 5-HT(1A) receptor following treatment of native membranes with cholesterol oxidase. Cholesterol oxidase is a water soluble enzyme that acts on the membrane interface to catalyze the conversion of cholesterol to cholestenone. Oxidation of membrane cholesterol significantly inhibits the specific binding of the agonist and antagonist to 5-HT(1A) receptors. Fluorescence polarization measurements of membrane probes incorporated at different locations in the membrane revealed no appreciable effect on membrane order due to the oxidation of cholesterol to cholestenone. These results therefore suggest that the ligand binding function of the 5-HT(1A) receptor is a cholesterol-dependent phenomenon that is not related to the ability of cholesterol to modulate membrane order. Importantly, these results represent the first report on the effect of a cholesterol-modifying agent on the ligand binding function of this important neurotransmitter receptor.",
     "FAU": [
          "Pucadyil, Thomas J",
          "Shrivastava, Sandeep",
          "Chattopadhyay, Amitabha"
     ],
     "AU": [
          "Pucadyil TJ",
          "Shrivastava S",
          "Chattopadhyay A"
     ],
     "AD": "Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Biochem Biophys Res Commun",
     "JT": "Biochemical and biophysical research communications",
     "JID": "0372516",
     "RN": [
          "0 (Ligands)",
          "0 (Serotonin 5-HT1 Receptor Agonists)",
          "0 (Serotonin 5-HT1 Receptor Antagonists)",
          "112692-38-3 (Receptor, Serotonin, 5-HT1A)",
          "97C5T2UQ7J (Cholesterol)",
          "EC 1.1.3.6 (Cholesterol Oxidase)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Cattle",
          "Cell Membrane/chemistry/*metabolism",
          "Cholesterol/chemistry/*metabolism",
          "Cholesterol Oxidase/metabolism",
          "Fluorescence Polarization",
          "Hippocampus/cytology/*metabolism",
          "Ligands",
          "Oxidation-Reduction",
          "Protein Binding",
          "Receptor, Serotonin, 5-HT1A/*metabolism",
          "Serotonin 5-HT1 Receptor Agonists",
          "Serotonin 5-HT1 Receptor Antagonists"
     ],
     "EDAT": "2005/04/27 09:00",
     "MHDA": "2005/07/22 09:00",
     "CRDT": [
          "2005/04/27 09:00"
     ],
     "PHST": [
          "2005/03/18 00:00 [received]",
          "2005/04/27 09:00 [pubmed]",
          "2005/07/22 09:00 [medline]",
          "2005/04/27 09:00 [entrez]"
     ],
     "AID": [
          "S0006-291X(05)00695-9 [pii]",
          "10.1016/j.bbrc.2005.03.178 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Biochem Biophys Res Commun. 2005 Jun 3;331(2):422-7. doi: 10.1016/j.bbrc.2005.03.178.",
     "term": "hippocampus"
}